Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)
Clinical trial NCT02750306 · COMPLETED
Trial details
- NCT number
- NCT02750306
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-23
- Primary completion
- 2018-09-30
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.